All stocks Β· BLUEJET
BJ

Blue Jet Healthcare Limited

BLUEJET BSE Healthcare

Blue Jet Healthcare Limited engages in the manufacturing and sale of artificial sweeteners, pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in products. It provides contrast media inter…

ISIN INE0KBH01020
Listed β€”
Quarters tracked 13
Filings 7 docs

About

Blue Jet Healthcare Limited engages in the manufacturing and sale of artificial sweeteners, pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in products. It provides contrast media intermediates, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related supplies to healthcare, pharma, animal feed, and food and beverages industries. It has operations in India, Norway, France, the United States, Denmark, Thailand, Spain, Italy, Sweden, and internationally. Blue Jet Healthcare Limited was incorporated in 1968 and is headquartered in Thane, India.

Key Metrics

as of Sep 2026
Market Cap10,785 Cr
P/E76.50
Div Yield0.21 %
Book Valueβ€”
52w Highβ‚Ή760.00
52w Lowβ‚Ή325.00
Face Valueβ‚Ή2.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 293.00 235.00 192.00 165.00 355.00 340.00 318.00 208.00 163.00 184.00 167.00 181.00 180.00
Expenses 195.00 163.00 146.00 111.00 234.00 200.00 194.00 139.00 119.00 131.00 112.00 119.00 121.00
Operating Profit 98.00 71.00 47.00 55.00 121.00 140.00 124.00 69.00 44.00 53.00 55.00 63.00 59.00
OPM % 33.00 30.00 24.00 33.00 34.00 41.00 39.00 33.00 27.00 29.00 33.00 35.00 33.00
Other Income 15.00 23.00 13.00 24.00 8.00 12.00 13.00 12.00 9.00 9.00 -3.00 8.00 5.00
Depreciation 7.00 6.00 6.00 6.00 6.00 5.00 5.00 5.00 3.00 8.00 8.00 6.00 6.00
Interest 1.00 1.00 0.00 5.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax 106.00 87.00 54.00 69.00 123.00 147.00 132.00 77.00 49.00 54.00 44.00 64.00 58.00
Tax % 26.00 26.00 25.00 24.00 26.00 25.00 25.00 24.00 24.00 27.00 27.00 26.00 24.00
Net Profit 78.00 64.00 40.00 52.00 91.00 110.00 99.00 58.00 38.00 40.00 32.00 48.00 44.00
EPS in Rs 4.51 3.71 2.32 3.01 5.26 6.35 5.71 3.36 2.18 2.29 1.85 2.76 2.54

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Sales 947.001,030.00712.00721.00683.00499.00538.00
Expenses 653.00652.00481.00502.00434.00292.00325.00
Operating Profit 294.00378.00231.00219.00249.00207.00214.00
OPM % 31.0037.0032.0030.0036.0041.0040.00
Other Income 69.0046.0018.0024.0019.009.006.00
Interest 6.000.000.001.003.005.007.00
Depreciation 24.0018.0028.0025.0022.0020.0018.00
Profit before tax 333.00406.00220.00217.00243.00190.00194.00
Tax % 25.0025.0026.0026.0025.0026.0025.00
Net Profit 248.00305.00164.00160.00182.00142.00145.00
EPS in Rs 14.2917.599.449.2310.471,428.7724,118.33
Dividend Payout % 8.007.0011.000.000.000.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Equity Capital 35.0035.0035.0035.0035.0010.000.60
Reserves 1,325.001,098.00811.00647.00487.00330.00198.00
Borrowings 44.0021.003.005.0019.0052.0074.00
Other Liabilities 238.00263.00211.00176.00173.00142.0092.00
Total Liabilities 1,641.001,418.001,059.00862.00713.00534.00364.00
Fixed Assets 316.00300.00172.00151.00156.00139.00107.00
CWIP 301.0089.00147.0030.003.003.002.00
Investments 252.00187.00250.00189.0094.0037.0026.00
Other Assets 771.00841.00489.00491.00460.00355.00229.00
Total Assets 1,641.001,418.001,059.00862.00713.00534.00364.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Cash from Operating Activity 334.0046.00241.00142.00146.00137.00122.00
Cash from Investing Activity -276.00-35.00-264.00-147.00-76.00-61.00-45.00
Cash from Financing Activity -31.00-19.00-2.00-4.00-56.00-21.00-72.00
Net Cash Flow 28.00-8.00-24.00-10.0014.0055.005.00
Free Cash Flow 115.00-34.0068.0083.00125.0085.00106.00
CFO/OP % 151.0036.00109.0092.0070.0066.0080.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Debtor Days 131.00124.0091.00121.00121.00105.0080.00
Inventory Days 157.00209.00151.00137.00133.00253.00120.00
Days Payable 48.0070.0035.0058.0072.00128.0090.00
Cash Conversion Cycle 240.00262.00206.00199.00183.00231.00110.00
Working Capital Days 136.00157.0092.00120.00103.0089.0055.00
ROCE % 26.0040.0030.0035.0053.0058.00β€”

Shareholding Pattern

% holding β€” latest first
Holder Jul 2026 Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023
Promoters 73.15 79.81 79.81 79.81 79.81 86.00 86.00 86.00 86.00 86.00 86.00 86.00
FIIs 0.63 0.40 0.89 1.14 1.83 1.97 2.28 1.10 2.18 2.02 2.01 2.93
DIIs 9.11 4.65 4.51 4.65 3.63 0.95 1.33 2.02 1.75 2.14 3.04 3.70
Public 17.11 15.14 14.80 14.41 14.74 11.08 10.38 10.87 10.06 9.83 8.97 7.37
No. of Shareholders 78,927 78,917 79,199 80,187 80,117 70,772 54,581 43,003 41,933 42,882 48,625 55,589

Corporate Actions

3 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Dividend 19 Sep 2025 19 Sep 2025 β€” 1.20
Dividend 17 Sep 2024 18 Sep 2024 β€” 1.00
Other 17 Sep 2024 β€” β€” β€” Annual General Meeting

Announcements

5 filings